Baker Bros. Advisors’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Baker Bros. Advisors’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,580,873	Closed	-$94.5M	–	126
2020 Q2	$94.5M	Sell	1,580,873 -374,540	-19%	-$23.1M	0.42%	18
2020 Q1	$116M	Buy	1,955,413 +167,456	+9%	+$9.76M	0.72%	13
2019 Q4	$97.9M	Buy	1,787,957 +133,928	+8%	+$5M	0.52%	21
2019 Q3	$46.7M	Sell	1,654,029 -133,778	-7%	-$4.91M	0.32%	25
2019 Q2	$59.3M	Hold	1,787,807	–	–	0.4%	25
2019 Q1	$60.8M	Hold	1,787,807	–	–	0.39%	27
2018 Q4	$49M	Hold	1,787,807	–	–	0.4%	23
2018 Q3	$52.2M	Buy	+1,787,807	New	+$50.5M	0.34%	26

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Baker Bros. Advisors's PRNB Position: Q3 2020 in Review

Baker Bros. Advisors sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,580,873 shares — an estimated $94.5M sold.

Baker Bros. Advisors first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $116M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Baker Bros. Advisors reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Baker Bros. Advisors sold 1,580,873 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $94.5M.
Baker Bros. Advisors first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Baker Bros. Advisors's Principia Biopharma Inc. Common Stock position peaked at $116M in Q1 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Baker Bros. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.